Approved arrhythmia drug may slow MYC-driven lymphoma by blocking USP11 interactions
A team of researchers at VCU Massey Comprehensive Cancer Center discovered an innovative way to use a drug already approved for treating irregular heartbeat to selectively target specific functions of enzymes in lymphoma, ...
Feb 5, 2026
0
0
